Heart Failure Awareness – why should we care?
February is Heart Awareness Month. In this Insight, Karin Kleinhans of LSP discusses how heart failure, one of the leading causes of death worldwide, is a global problem that demands urgent attention.
February is Heart Awareness Month. In this Insight, Karin Kleinhans of LSP discusses how heart failure, one of the leading causes of death worldwide, is a global problem that demands urgent attention.
Francesco de Rubertis, a co-founder of Medicixi Ventures, has unveiled the next … Continue reading “BioWorld Article by Mike Ward on Medicxi’s launch of Centessa Pharmaceuticals”
CEO Neil Clark and CSO Dr Bill Love from Europe’s leading anti-infectives biotech company Destiny Pharma, on how the makers and influencers of health policy could fuel a renaissance in drug development…
Novo Seeds had a very successful year with five investments. Also, substantial progress has been made across the 25 biotech companies in the portfolio, with 12 drug candidates now in the clinic.
2021: Priorities for European Pharma & What does the investment landscape look like post Covid-19?
From surviving to thriving as 2021 takes the reins from 2020. In a year turned on its head by the pandemic, witnessing this month the unprecedented roll out of a novel coronavirus vaccine, with several more vaccines on the horizon, December has become a time of hope…
Whilst the news is, finally, full of promising updates on vaccines, the world will need a wide range of prophylactic and therapeutic approaches to defeat the coronavirus.
Jonathan Tobin, Managing Director of Arix, talks to Vox Markets
Start planning early for the Virtual J.P. Morgan Healthcare Conference (“JPM”)
Against the backdrop of the pandemic and Brexit, Biocomposites’ lead product STIMULAN became the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft-tissue.
Fireside Chat: ‘Communicating to investors through a crisis’ Chaired by Mary Clark, with Kevin Mannix, Head of IR at Teva, and Oliver Maier, Head of IR at Bayer
Fireside Chat with Dan Mahony, Co-head of Healthcare, Polar Capital & Kieran Murphy, President & CEO, GE Healthcare
Tuning in to the field of targeted cancer medicine through molecular radiotherapy or targeted radionuclides.
Congratulations to Kiadis Pharma on recently announcing that it is being acquired by Sanofi in a … Continue reading “Sanofi offers to acquire Kiadis for €308 million”
Chair: Clive Cookson, Science Editor, Financial Times Sean Marett, Chief Business and … Continue reading “Covid-19: The Industry Response – How Are we Doing?”
This year, in collaboration with Dechert, we held a virtual version of … Continue reading “Desperately Seeking Serendipity – Engaging in the new virtual”
Check out the full agenda and speakers via the conference website. Register now.
Optimum’s 12th Annual Healthcare Investor Conference features panel with eminent industry leaders. Read more here and register your interest to join the virtual event live on 8th October 2020
co-hosted with Dechert LLP, Thursday 8th October 2020. The first speakers to be announced…
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...
GET IN TOUCH
© Copyright 2021 Optimum Strategic Communications All rights reserved.
The Spice Building
8 Devonshire Square
London
EC2M 4PL
Tel: +44 (0)203 950 9144
Email: contact@optimumcomms.com
